calendar
7,964 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
7,964 catalysts · 5,063 phase readout · 2,335 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
Items: 7.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 5.02, 7.01, 8.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 1.01, 7.01, 9.01
Items: 8.01, 9.01
Items: 5.07, 8.01, 9.01
Items: 3.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 4.01, 9.01
Items: 1.01, 1.02, 2.02, 7.01, 8.01, 9.01
Items: 1.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.05
Items: 2.02, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 1.01, 9.01
Items: 5.02
Items: 5.03, 9.01
Items: 2.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 8.01
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 1.01, 3.02, 9.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL